Table 4.
Long COVID symptoms and eating behavior.
LC+SAT+ED (n = 6) | LC+SAT (n = 18) | |
---|---|---|
Long-lasting GI symptoms | Changes in quality of taste and smell: 6 (100.0%) | Changes in quality of taste and smell: 18 (100.0%) |
Reduced smell and taste: 3 (50.0%) | Reduced smelling and tasting: 9 (50.0%) | |
Reduced appetite: 5 (83.3%) | Reduced appetite: 2 (11.1%) | |
Abdominal pain: 0 | Abdominal pain: 3 (16.7%) | |
Constipation: 2 (33.3%) | Constipation: 4 (22.2%) | |
Somatic symptoms of eating disorder | Irregular menstrual cycle: 3 (100.0% of females) | Irregular menstrual cycle: 2 (15.4% of females) |
95%-CI: 0.0-1.07 | 95%-CI: 0.0-0.27 | |
Hair loss: | Hair loss: | |
3 (50.0%), 95%-CI: 0.00–1.07 | 2 (11.1%), 95%-CI: 0.0-0.27 | |
Sleep problems: 3 (50.0%) | Sleep problems: 6 (33.3%) | |
Fatigue: 3 (50.0%) | Fatigue: 6 (33.3%) | |
Less condition: 5 (83.3%) | Less condition: 16 (88.9%) | |
Headache: 4 (66.7%) | Headache: 14 (77.8%) | |
Dyspnea: 1 (16.7%) | Dyspnea: 6 (33.3%) | |
Other long-lasting symptoms | Paresthesia: 2 (33.3%) | Paresthesia: 10 (55.6%) |
Palpitation: 3 (50.0%) | Palpitation: 4 (22.2%) | |
Concentration problems: 4 (66.7%) | Concentration problems: 8 (44.4%) | |
Chest pain: 1 (16.7%) | Chest pain: 1 (5.6%) | |
Vertigo: 1 (16.7%) | Vertigo: 4 (22.2%) | |
Psychological symptoms | Self-reported depression symptoms: 5 (83.3%) | Self-reported depression symptoms: 5 (27.8%) |
Self-reported anxiety symptoms: 4 (66.7%) | Self-reported anxiety symptoms: 5 (27.8%) | |
95%-CI: 0.40–1.26 | 95%-CI: 0.05–0.51 | |
Restrictive eating behavior | Restrictive eating behavior: 6 | 0 |
95%-CI: 1.0–1.0 | 95%-CI: 0.0–0.0 | |
Permanent weight control | 2 (33.3%) | 0 |
Body Scheme | Distorted body image: 4 (66.7%) | Distorted body image: 1 (5.6%) |
Body checking: 2 (33.3%) | ||
Suicidal ideation | Suicidal thoughts: 1 (16.7%) | None |